Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

NCT02244944 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Failure to recruit

Conditions

Nonalcoholic Fatty Liver Disease (NAFLD)

Interventions

DRUG: EZ-Urso combination therapy

Sponsor

Gregory Graf, PhD